Anti-cancer drugs for the treatment of leukaemias I, constituted by the chain A of ricin and a specific monoclanal antibody
US4643895A · kind A · utility
5Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 1, 1982 |
| Grant date | Feb 17, 1987 |
| Priority date | — |
| Expiry date | Nov 1, 2002 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/866
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an anti-cancer drug, characterized in that it contains at least one product constituted by the chain A of recin conjugated by means of a disulfide bridge with at least one fraction of a monoclonal antibody of leukaemic anti-cell specificity, and to the processes for preparing the active ingredient of said drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.